NM_015450.3:c.1127A>G

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting

The NM_015450.3(POT1):​c.1127A>G​(p.Gln376Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00052 in 1,602,376 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q376H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00041 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00053 ( 0 hom. )

Consequence

POT1
NM_015450.3 missense

Scores

1
7
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:11B:3

Conservation

PhyloP100: 3.84

Publications

9 publications found
Variant links:
Genes affected
POT1 (HGNC:17284): (protection of telomeres 1) This gene is a member of the telombin family and encodes a nuclear protein involved in telomere maintenance. Specifically, this protein functions as a member of a multi-protein complex that binds to the TTAGGG repeats of telomeres, regulating telomere length and protecting chromosome ends from illegitimate recombination, catastrophic chromosome instability, and abnormal chromosome segregation. Increased transcriptional expression of this gene is associated with stomach carcinogenesis and its progression. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]
POT1 Gene-Disease associations (from GenCC):
  • pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • tumor predisposition syndrome 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • glioma susceptibility 9
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • thyroid gland carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • cerebroretinal microangiopathy with calcifications and cysts 3
    Inheritance: AR Classification: LIMITED Submitted by: G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07021743).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000414 (63/152262) while in subpopulation NFE AF = 0.000632 (43/68012). AF 95% confidence interval is 0.000482. There are 0 homozygotes in GnomAd4. There are 32 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015450.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POT1
NM_015450.3
MANE Select
c.1127A>Gp.Gln376Arg
missense
Exon 13 of 19NP_056265.2Q9NUX5-1
POT1
NM_001042594.2
c.734A>Gp.Gln245Arg
missense
Exon 12 of 18NP_001036059.1A8MTK3
POT1
NR_003102.2
n.1690A>G
non_coding_transcript_exon
Exon 14 of 20

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POT1
ENST00000357628.8
TSL:2 MANE Select
c.1127A>Gp.Gln376Arg
missense
Exon 13 of 19ENSP00000350249.3Q9NUX5-1
POT1
ENST00000607932.5
TSL:1
n.1127A>G
non_coding_transcript_exon
Exon 9 of 14ENSP00000476506.1Q5MJ34
POT1
ENST00000608057.5
TSL:1
n.*224A>G
non_coding_transcript_exon
Exon 10 of 16ENSP00000476371.1Q5MJ35

Frequencies

GnomAD3 genomes
AF:
0.000414
AC:
63
AN:
152144
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00404
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000632
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000447
AC:
107
AN:
239174
AF XY:
0.000457
show subpopulations
Gnomad AFR exome
AF:
0.0000622
Gnomad AMR exome
AF:
0.000358
Gnomad ASJ exome
AF:
0.00372
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000514
Gnomad OTH exome
AF:
0.000339
GnomAD4 exome
AF:
0.000532
AC:
771
AN:
1450114
Hom.:
0
Cov.:
30
AF XY:
0.000524
AC XY:
378
AN XY:
721080
show subpopulations
African (AFR)
AF:
0.0000306
AC:
1
AN:
32710
American (AMR)
AF:
0.000319
AC:
13
AN:
40774
Ashkenazi Jewish (ASJ)
AF:
0.00411
AC:
106
AN:
25804
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39544
South Asian (SAS)
AF:
0.0000121
AC:
1
AN:
82904
European-Finnish (FIN)
AF:
0.0000563
AC:
3
AN:
53332
Middle Eastern (MID)
AF:
0.00105
AC:
6
AN:
5738
European-Non Finnish (NFE)
AF:
0.000535
AC:
593
AN:
1109314
Other (OTH)
AF:
0.000800
AC:
48
AN:
59994
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
36
71
107
142
178
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000414
AC:
63
AN:
152262
Hom.:
0
Cov.:
32
AF XY:
0.000430
AC XY:
32
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41570
American (AMR)
AF:
0.000131
AC:
2
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00404
AC:
14
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000632
AC:
43
AN:
68012
Other (OTH)
AF:
0.00
AC:
0
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000547
Hom.:
1
Bravo
AF:
0.000351
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000698
AC:
6
ExAC
AF:
0.000395
AC:
48
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000767
EpiControl
AF:
0.000950

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
5
-
not provided (5)
-
2
1
not specified (3)
-
1
1
Hereditary cancer-predisposing syndrome (2)
-
1
1
Tumor predisposition syndrome 3 (2)
-
1
-
Diffuse midline glioma, H3 K27-altered (1)
-
1
-
Hereditary cancer (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Uncertain
-0.080
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.34
T
Eigen
Uncertain
0.68
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.85
T
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.070
T
MetaSVM
Benign
-0.43
T
MutationAssessor
Uncertain
2.8
M
PhyloP100
3.8
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-2.1
N
REVEL
Benign
0.26
Sift
Uncertain
0.0020
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.82
MVP
0.61
MPC
0.095
ClinPred
0.15
T
GERP RS
5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.61
gMVP
0.63
Mutation Taster
=12/88
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143635917; hg19: chr7-124482897; API